Author:
Kapoor Kapil G.,Hodge David O.,St. Sauver Jennifer L.,Barkmeier Andrew J.
Reference30 articles.
1. U.S. outpatient antibiotic prescribing, 2010 [letter];Hicks;N Engl J Med,2013
2. Antimicrobial safety: focus on fluoroquinolones;Owens;Clin Infect Dis,2005
3. Fluoroquinolone-associated tendinopathy: a critical review of the literature;Khaliq;Clin Infect Dis,2003
4. Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population;Hall;PM R,2011
5. U.S. Food and Drug Administration. NDA 21158/S-018. Factive (gemifloxacin mesylate). Supplement approval [letter]. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021158s018ltr.pdf. Accessed December 1, 2013.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献